The evolving use of radioiodine therapy in differentiated thyroid cancer.

@article{Mayson2015TheEU,
  title={The evolving use of radioiodine therapy in differentiated thyroid cancer.},
  author={Sarah E. Mayson and Don C. Yoo and Geetha Gopalakrishnan},
  journal={Oncology},
  year={2015},
  volume={88 4},
  pages={247-56}
}
The incidence of differentiated thyroid cancer has increased worldwide over the last three decades, but thyroid cancer-related mortality remains stable. Until recently, the standard treatment for most thyroid cancers has been near-total thyroidectomy followed by radioiodine remnant ablation. Observational data support lower recurrence rates and improved survival after radioiodine ablation in patients with high-risk cancers; however, a similar benefit has not been established for all patients… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 1 time over the past 90 days. VIEW TWEETS